What the research is about
Researchers have identified a connection between a protein called EVA1A and CD36, a transporter that helps move fatty acids into cells, in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). The report, published by News-Medical, describes EVA1A as a regulator of CD36 in the context of fatty liver disease.
MASLD is defined by an excessive build-up of lipids inside hepatocytes, the main functional cells of the liver. This lipid overload is a central feature of the disease and is tied to broader metabolic dysfunction.
Why MASLD is drawing attention
MASLD has become one of the most common chronic liver diseases worldwide. Health experts link its growing burden to the rapid increase in insulin resistance, obesity and diabetes prevalence across many populations.
Because these metabolic conditions are rising quickly, MASLD is also being recognised as a major public health issue that extends beyond liver care alone, intersecting with diabetes management and weight-related health risks.
EVA1A and CD36: the link highlighted
According to the report, EVA1A regulates CD36, a fatty acid transporter. CD36 is known for its role in facilitating the uptake of fatty acids into cells, which makes it relevant to diseases marked by abnormal fat accumulation.
By identifying EVA1A as a regulator of CD36 in MASLD, the findings add a new detail to the biological picture of how lipid build-up may be controlled within liver cells.
What this means for understanding fatty liver disease
The new information focuses on mechanisms connected to fat handling in the liver, an area central to MASLD. Excess lipid storage in hepatocytes is the defining feature of the condition, and proteins involved in fatty acid transport are closely watched in research on disease development and progression.
News-Medical notes the global context of MASLD, underscoring that the disease is closely associated with rising rates of insulin resistance, obesity and diabetes. The report frames the EVA1A CD36 relationship within this broader metabolic trend.